Nephrocare Health Services Limited (NEPHROPLUS) — Board Meeting

📢 Key Event
Board approved financial support for overseas subsidiaries NHCSPI and NHSI

🔄 What Changed
Corporate guarantee of USD 5.5 million (INR 52.46 Crore) executed for Citibank N.A. and collateral support of USD 3.315 million (INR 31.26 Crore) provided to HSBC

🔮 What's Next
Ensure timely reporting of similar events going forward

💡 Investor Takeaway
These contingent liabilities require monitoring but pose no immediate operational or liquidity impact

Nephrocare Health Services Limited disclosed two board-approved financial support actions executed on May 29 and June 24, 2026, providing USD 5.5 million (INR 52.46 Crore) corporate guarantee for Citibank N.A. to secure credit facilities for its Philippine subsidiary NHCSPI, and USD 3.315 million (INR 31.26 Crore) collateral support for HSBC to enable funding for its Singapore subsidiary NHSI. Both transactions were disclosed under SEBI Regulation 30 to rectify prior administrative oversights, with no material impact on operations or liquidity. The company emphasized arm's length execution and will ensure timely future reporting of such events.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NEPHROPLUS ✨ Ask AI About This